Results 91 to 100 of about 526 (116)

Afamelanotide

, 2010
E.I. Minder
core   +1 more source

Molecular Targets in Modern Cosmetic Science. [PDF]

Molecules
Popiół-Adamska J, Łagosz K, Kolisz M, Uniwersał K, Kabat-Walewska M, Shuha Y, Lourith N, Kanlayavattanakul M, Gunia-Krzyżak A.   +8 more
europepmc   +1 more source

Up-and-Coming Drugs for the Treatment of Vitiligo. [PDF]

Ann Dermatol
Seong SH, Oh SH.
europepmc   +1 more source

Afamelanotide

, 2011
null &NA;
core   +1 more source

Erythropoietic protoporphyrias: Pathogenesis, diagnosis and management. [PDF]

Liver Int
Minder AE, Kluijver LG, Barman-Aksözen J, Minder EI, Langendonk JG.   +4 more
europepmc   +1 more source

Quality of life in children with erythropoietic protoporphyria: a case-control study. [PDF]

J Dermatol
Kluijver LG, Wensink D, Wagenmakers MAEM, Huidekoper HH, Witters P, Rymen D, Langendonk JG.   +6 more
europepmc   +1 more source

A systematic review of case series and clinical trials investigating systemic oral or injectable therapies for the treatment of vitiligo. [PDF]

Skin Res Technol
Jafarzadeh A, Pour Mohammad A, Khosravi M, Amiri S, Rasouli A, Keramati H, Goodarzi A.   +6 more
europepmc   +1 more source

Clinical Use and Safety of Self-Tanner (Topical Dihydroxyacetone) in Dermatology: A Systematic Review. [PDF]

J Cutan Med Surg
Laferté C, Oliel S, Pehr K.
europepmc   +1 more source